3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide

C26H32BrN3O3S — CID 130316015

IUPAC3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide
SMILESCO/N=C1\CC(CCC(=O)Nc2ncc(C)s2)C2C3CCc4c(ccc(O)c4Br)C3CCC12C
InChIInChI=1S/C26H32BrN3O3S/c1-14-13-28-25(34-14)29-22(32)9-4-15-12-21(30-33-3)26(2)11-10-17-16-7-8-20(31)24(27)19(16)6-5-18(17)23(15)26/h7-8,13,15,17-18,23,31H,4-6,9-12H2,1-3H3,(H,28,29,32)/b30-21+
InChIKeyWILAQVPWFTYUGC-MWAVMZGNSA-N
MW546.53 g/mol
LogP6.42
Rot. Bonds5

About 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide

3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide (PubChem CID 130316015) has the molecular formula C26H32BrN3O3S and a molecular weight of 546.53 g/mol. Its IUPAC name is 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide.

Molecular Properties

Compound Name3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide
PubChem CID130316015
Molecular FormulaC26H32BrN3O3S
Molecular Weight546.53 g/mol
Exact Mass545.13
IUPAC Name3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide
SMILESCO/N=C1\CC(CCC(=O)Nc2ncc(C)s2)C2C3CCc4c(ccc(O)c4Br)C3CCC12C
InChIInChI=1S/C26H32BrN3O3S/c1-14-13-28-25(34-14)29-22(32)9-4-15-12-21(30-33-3)26(2)11-10-17-16-7-8-20(31)24(27)19(16)6-5-18(17)23(15)26/h7-8,13,15,17-18,23,31H,4-6,9-12H2,1-3H3,(H,28,29,32)/b30-21+
InChIKeyWILAQVPWFTYUGC-MWAVMZGNSA-N
XLogP6.42
TPSA83.81 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500546.53
LogP ≤ 56.42
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide?
The IUPAC name of 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide (CID 130316015) is 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide.
What is the SMILES notation for 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide?
The canonical SMILES for 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide is CO/N=C1\CC(CCC(=O)Nc2ncc(C)s2)C2C3CCc4c(ccc(O)c4Br)C3CCC12C.
What is the InChIKey of 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide?
The InChIKey is WILAQVPWFTYUGC-MWAVMZGNSA-N. The full InChI is InChI=1S/C26H32BrN3O3S/c1-14-13-28-25(34-14)29-22(32)9-4-15-12-21(30-33-3)26(2)11-10-17-16-7-8-20(31)24(27)19(16)6-5-18(17)23(15)26/h7-8,13,15,17-18,23,31H,4-6,9-12H2,1-3H3,(H,28,29,32)/b30-21+.
What are the key properties of 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide?
3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide has a molecular weight of 546.53 g/mol, XLogP of 6.42, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(17E)-4-bromo-3-hydroxy-17-methoxyimino-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)propanamide is sourced from PubChem (CID 130316015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).